Gisela Kobelt (Former)
1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved.
(
- Contribution to journal › Article
-
Mark
Annual direct medical cost of active systemic lupus erythematosus in five European countries
(
- Contribution to journal › Article
- 2013
-
Mark
Health economic evaluation: why? When? How?
(
- Contribution to journal › Scientific review
-
Mark
The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
(
- Contribution to journal › Article
- 2012
-
Mark
A framework for improving the quality of care for people with psoriasis
(
- Contribution to journal › Article
-
Mark
Cost of multiple sclerosis in the Czech Republic: The COMS study
(
- Contribution to journal › Article
-
Mark
Economic studies in rheumatology: data, perspectives, challenges.
(
- Contribution to journal › Article
- 2011
-
Mark
Cost of disorders of the brain in Europe 2010
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
(
- Contribution to journal › Article
- 2010
-
Mark
Cost of Illness from the Public Payers' Perspective in Patients with Ankylosing Spondylitis in Rheumatological Care.
(
- Contribution to journal › Article